Greenline Wealth Management’s Insmed INSM Stock Holding History

Greenline Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-847	Closed	-$147K	–	293
2025 Q4	$147K	Buy	+847	New	+$155K	0.15%	103

Other funds holding INSM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Greenline Wealth Management's INSM Position: Q1 2026 in Review

Greenline Wealth Management sold out of Insmed (INSM) in Q1 2026, closing a stake of 847 shares — an estimated $147K sold.

Greenline Wealth Management first reported a position in INSM in Q4 2025 and held it in 1 quarter. The position peaked at $147K in Q4 2025. 674 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Greenline Wealth Management reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
Greenline Wealth Management sold 847 Insmed shares in Q1 2026, an estimated $147K.
Greenline Wealth Management first reported a position in Insmed in Q4 2025 and held it in 1 quarter.
Greenline Wealth Management's Insmed position peaked at $147K in Q4 2025.
674 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Greenline Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.